|
CCNF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.028430E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.073200E-01 |
| Normal-vs-Stage2 |
6.358100E-02 |
| Normal-vs-Stage3 |
4.939800E-02 |
| Normal-vs-Stage4 |
6.975600E-02 |
| Stage1-vs-Stage2 |
2.372600E-01 |
| Stage1-vs-Stage3 |
9.466000E-02 |
| Stage1-vs-Stage4 |
2.212800E-01 |
| Stage2-vs-Stage3 |
9.581200E-01 |
| Stage2-vs-Stage4 |
9.722600E-01 |
| Stage3-vs-Stage4 |
9.915600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.069400E-01 |
| Normal-vs-AfricanAmerican |
1.628420E-02 |
| Normal-vs-Asian |
1.751990E-01 |
| Caucasian-vs-AfricanAmerican |
7.515600E-02 |
| Caucasian-vs-Asian |
7.254400E-01 |
| AfricanAmerican-vs-Asian |
1.213820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.413950E-01 |
| Normal-vs-Female |
9.736200E-02 |
| Male-vs-Female |
7.347600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.421000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.416200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.439900E-02 |
| Normal-vs-Age(81-100Yrs) |
9.182200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.718100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.950200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.182800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.304800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.140840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.432000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.487550E-01 |
| Classical-VS-Follicular |
1.50687000000094E-05 |
| Classical-VS-Other |
2.930000E-01 |
| Classical-VS-Normal |
2.703200E-01 |
| Tall-VS-Follicular |
2.306000E-01 |
| Tall-VS-Other |
7.507000E-01 |
| Tall-VS-Normal |
5.767700E-02 |
| Follicular-VS-Other |
7.735800E-01 |
| Follicular-VS-Normal |
4.399600E-03 |
| Other-VS-Normal |
3.056200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.472160E-01 |
| Normal-vs-N1 |
1.562210E-02 |
| N0-vs-N1 |
3.062000E-02 |
|
|
